Magnetar Financial’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Magnetar Financial’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,053,882	Closed	-$97.9M	–	1638
2021 Q4	$97.9M	Buy	+1,053,882	New	+$69.4M	0.98%	20
2020 Q2	–	Sell	-6,933	Closed	-$291K	–	612
2020 Q1	$291K	Buy	+6,933	New	+$318K	0.01%	348
2019 Q4	–	Sell	-4,997	Closed	-$229K	–	673
2019 Q3	$229K	Buy	+4,997	New	+$281K	0.01%	426

Magnetar Financial's ARNA Position: Q1 2022 in Review

Magnetar Financial sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 1,053,882 shares — an estimated $97.9M sold.

Magnetar Financial first reported a position in ARNA in Q3 2019 and held it in 3 quarters. The position peaked at $97.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Magnetar Financial reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Magnetar Financial sold 1,053,882 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $97.9M.
Magnetar Financial first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 3 quarters.
Magnetar Financial's Arena Pharmaceuticals Inc position peaked at $97.9M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Magnetar Financial's 13F filing for Q1 2022, filed 16 May 2022.